Global Extracorporeal Membrane Oxygtioenan ECMO System Market Overview
Extracorporeal membrane oxygenation system is a device which provides respiratory and cardiac support to the patients suffering from severe respiratory failure. ECMO oxygenates the blood and remove carbon dioxide through extracorporeal gas exchange device. It consists of pump, cannulas, blender, and oxygenator. Nowadays, ECMO has become more consistent with development in equipment. In addition, change in dietary habits and lifestyle is leading to cause various chronic diseases including respiratory and cardiac disease, which in turn, increase the need of extracorporeal membrane oxygenation machine. The global extracorporeal membrane oxygenation (ECMO) System market accounted for US$ 285.3 million in 2019 and is estimated to be US$ 430.3 million by 2029 and is anticipated to register a CAGR of 4.2%.
COVID-19 Impact on the Market:
With the outbreak of the COVID-19, various businesses are at the forefront to combat this pandemic. The pandemic has hindered the industrial supply chain and also disrupted the production segment. Government across the countries has imposed strict lockdown to limit the spread of disease. However, increasing investments by prominent players and other industries has created growth opportunities, during this chaotic situation, to fulfill the demand of suppliers. This report will quantify the impact of this pandemic on the extracorporeal membrane oxygenation (ECMO) system market.
Global Extracorporeal Membrane Oxygtioenan ECMO System Market Dynamics
According to World Health Organization (WHO), nearly 17.7 million deaths i.e. around 31% of total global deaths was due to cardiovascular disease in 2015. In addition, according to European Heart Network AISBL, around 3.9 million and over 1.8 million deaths occurs every year in Europe and European Union respectively, which estimated around 45% of all deaths in European Union. Thus, increasing prevalence of cardiac and respiratory diseases are driving growth of the global extracorporeal membrane oxygenation (ECMO) system. Currently, the world is experiencing the COVID-19 pandemic. This infection leads to acute & severe respiratory disorders, multiple organ failure, pneumonia, and even death in severe cases.
Advent of innovative products and significant investments by key players
Getinge, Medtronic, LivaNova, Alung Technologies, Terumo, and Abbott are some of the notable industry players in the market. New product launches, strategic collaboration and partnerships, merger and acquisitions, are major strategies followed by these companies. Introduction of innovative products and significant investment towards research and development by the companies has accelerated the competition in the market. For instance, in September 2017, CytoSorbents Corporation launched the CytoSorb Therapeutic ECMO kit in Austria. This kit enables CytoSorb blood purification cartridge with innovative tubing connector set that allows easy integration in most of the commercial ECMO systems available in the market.
On the flip side, high cost and lack of skilled professionals is a challenge to the market. In addition, complications related with the target market such as infections, bleeding, and technical failures might hamper growth of the global market.
Global Extracorporeal Membrane Oxygtioenan ECMO System Market Segmentation
The global extracorporeal membrane oxygenation (ECMO) system market is segmented based on the modality, application, age group, and region.
Depending upon the modality, the global business is categorized into arteriovenous, venoarteial, and venovenous. In terms of application, the worldwide industry is categorized into extracorporeal cardiopulmonary resuscitation, cardiac, and respiratory. Based on the age group, the target market is segmented into neonatal, pediatric, and adults.
Regional Insights:
Regionally, the overall industry is divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America extracorporeal membrane oxygenation machine market is at the forefront, due to the presence of major players and repeated product launches. In addition, increasing prevalence of diseases such as chronic obstructive pulmonary disease (COPD) in the U.S and high purchasing power parity of patients are driving growth of the market in this region. Furthermore, government support for quality healthcare, sophisticated healthcare facilities and favorable reimbursement policies has propelled the usage rate of ECMO machines. Whereas, the Asia Pacific extracorporeal membrane oxygenation machines market is projected to register the fastest growth in the upcoming years, owing to increasing healthcare expenditure by private and government agencies in order to improve healthcare facilities. Along with this, economic development in countries such as India, Japan, and China are creating growth opportunities for the market.
Report Scope:
|
Attribute |
Details |
|
The base year for estimation |
2019 |
|
Forecast period |
2019 – 2029 |
|
Market representation |
Revenue in USD Million & CAGR from 2019 – 2029 |
|
Market Segmentation |
By Modality - Arteriovenous, Venoarteial, and Venovenous By Application - Extracorporeal cardiopulmonary resuscitation, Cardiac, and Respiratory By Age Group - Neonatal, Pediatric, and Adults |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the global extracorporeal membrane oxygenation (ECMO) system market report based on modality, application, age group, and region.
Global Extracorporeal Membrane Oxygenation (ECMO) System Market, By Modality:
- Arteriovenous
- Venoarteial
- Venovenous
Global Extracorporeal Membrane Oxygenation (ECMO) System Market, By Application:
- Extracorporeal cardiopulmonary resuscitation
- Cardiac
- Respiratory
Global Extracorporeal Membrane Oxygenation (ECMO) System Market, By Age Group:
- Neonatal
- Pediatric
- Adults
Global Extracorporeal Membrane Oxygenation (ECMO) System Market, By Region:
-
-
- North America
-
- U.S.
- Canada
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- North America
-
Global Extracorporeal Membrane Oxygtioenan ECMO System Market Key Players
The key players operating in the global extracorporeal membrane oxygenation (ECMO) system market include Getinge Group, Medtronic plc, LivaNova PLC, ALung Technologies, Inc., XENIOS AG, Terumo Corporation, MicroPort Scientific Corporation, OriGen Biomedical, Inc., NIPRO Corporation, and EUROSETS S.r.l. Companies are increasing their investments in R&D to expand its product portfolio and market presence. In April 2019, Hemovent GmbH announced that its next generation ECMO system, MOBYBOX, has been validated in a pilot in vivo study by Minnesota Resuscitation Consortium, which is designing a ‘super ambulance’ that will beequipped with the latest technology to advance treatment of cardiac-arrest emergency patients.
Global Extracorporeal Membrane Oxygtioenan ECMO System Market Company Profile
- Getinge Group
- Company Overview
- Modality Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
- Medtronic plc
- LivaNova PLC
- ALung Technologies, Inc.
- XENIOS AG
- Terumo Corporation
- MicroPort Scientific Corporation
- OriGen Biomedical, Inc.
- NIPRO Corporation
- EUROSETS S.r.l.
“*” marked represents similar segmentation in other categories in the respective section
Global Extracorporeal Membrane Oxygtioenan ECMO System Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for Extracorporeal Membrane Oxygenation (ECMO) System Strategies
- Key Questions this Study will Answer
- Market Snippet, By Modality
- Market Snippet, By Application
- Market Snippet, By Age Group
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Global Extracorporeal Membrane Oxygenation (ECMO) System Market, By Modality, 2019 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 – 2029
- Y-o-Y Growth Analysis (%), 2019 – 2029
- Segment Trends
- Arteriovenous
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Venoarteial
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Venovenous
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Overview
- Global Extracorporeal Membrane Oxygenation (ECMO) System Market, By Application, 2019 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 – 2029
- Y-o-Y Growth Analysis (%), 2019 – 2029
- Segment Trends
- Extracorporeal cardiopulmonary resuscitation
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Cardiac
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Respiratory
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Overview
- Global Extracorporeal Membrane Oxygenation (ECMO) System Market, By Age Group, 2019 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 – 2029
- Y-o-Y Growth Analysis (%), 2019 – 2029
- Segment Trends
- Neonatal
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Pediatric
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Adults
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Overview
- Global Extracorporeal Membrane Oxygenation (ECMO) System Market, By Region, 2019 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 – 2029
- Y-o-Y Growth Analysis (%), 2019 – 2029
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Modality, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Age Group, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Modality, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Age Group, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Modality, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Age Group, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Modality, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Age Group, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Modality, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Age Group, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
-
- Getinge Group
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
- Medtronic plc
- LivaNova PLC
- ALung Technologies, Inc.
- XENIOS AG
- Terumo Corporation
- MicroPort Scientific Corporation
- OriGen Biomedical, Inc.
- NIPRO Corporation
- EUROSETS S.r.l.
- Getinge Group
-
- The Last Word
- Future Impact
- About Us
- Contact
FAQs
The extracorporeal membrane oxygenation (ECMO) System market accounted for US$ 285.3 million in 2019 and is estimated to be US$ 430.3 million by 2029 and is anticipated to register a CAGR of 4.2%.
The market report has been segmented on the basis of modality, application, age group, and region.
Emerging trends include the development of portable and user-friendly ECMO systems, the expansion of ECMO applications beyond respiratory support, and the integration of advanced monitoring technologies, presenting significant opportunities in the global Extracorporeal Membrane Oxygenation (ECMO) System Market.
Factors driving the market include the increasing prevalence of respiratory failure and cardiac conditions, advancements in ECMO technology, the growing acceptance of ECMO as a life-saving intervention, and the rising awareness of ECMO benefits in critical care settings.
The report covers regions worldwide. North America is expected to dominate the Extracorporeal Membrane Oxygenation (ECMO) System Market, driven by a well-established healthcare system, a high incidence of cardiopulmonary diseases, and significant research and development activities in the region. Other influential regions include Europe and Asia-Pacific.
The prominent player operating in the global extracorporeal membrane oxygenation (ECMO) System market includes Getinge Group, Medtronic plc, LivaNova PLC, ALung Technologies, Inc., XENIOS AG, Terumo Corporation, MicroPort Scientific Corporation, OriGen Biomedical, Inc., NIPRO Corporation, and EUROSETS S.r.l.